Despite the recent advances in drug development, the majority of novel therapeutics have
not been successfully translated into clinical applications. One of the major factors hindering …

Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90%
of cancer-related deaths. The integrin ITGB3 has been previously described to play an …

Extracellular vesicles (EVs) are phospholipidic bi-layer enclosed nanoparticles secreted
naturally by all cell types. They are attracting increasing attention in the fields of …

Exosomes are a type of extracellular vesicle (EV) with diameters of 30–150 nm secreted by
most of the cells into the extracellular spaces and can alter the microenvironment through …

Extracellular vesicles (EVs) are constantly secreted from both eukaryotic and prokaryotic
cells. EVs, including those referred to as exosomes, may have an impact on cell signaling …

Extracellular vesicles (EV) are secreted by all cell types in a tumor and its microenvironment
(TME), playing an essential role in intercellular communication and the establishment of a …

Cell-derived extracellular vesicles (EVs) are currently in the limelight as potential disease
biomarkers. The promise of EV-based liquid biopsy resides in the identification of specific …

Extracellular vesicles (EVs) are diverse nanoparticles with large heterogeneity in size and
molecular composition. Although this heterogeneity provides high diagnostic value for liquid …

Extracellular vesicles (EVs) are membrane-bound vesicles secreted by most cell types and
exist in virtually all bodily fluids. They carry on a wealth of proteomic and genetic information …

In recent years, extracellular vesicles (EVs) emerged as potential diagnostic and prognostic
markers for cancer therapy. While the field of EV research is rapidly developing and their …